Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-11-04Clinical Trial Update: The Effect of Laughter Yoga on Blood Glucose Level, Disease Perception and Stress Level in Patients With Type 2 Diabetes [NA]
A completed clinical trial evaluating the effect of laughter yoga on blood glucose, disease perception, and stress in patients with type 2 d…
-
FDA approval · 2024-11-01FDA Approved: BYETTA — Supplemental Application (AstraZeneca Pharmaceuticals LP)
The FDA approved a supplemental application for BYETTA (exenatide) submitted by AstraZeneca Pharmaceuticals LP.
-
FDA approval · 2024-11-01FDA Approved: LIRAGLUTIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva Pharmaceuticals USA, Inc.'s supplemental application for liraglutide, updating the drug's labeling/indication.
-
FDA approval · 2024-11-01FDA Approved: OZEMPIC — Supplemental Application (Novo Nordisk)
FDA approved a supplemental application for Ozempic to expand its options by approving the oral semaglutide formulation for adults with type…
-
FDA approval · 2024-11-01FDA Approved: TRULICITY — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for TRULICITY (dulaglutide) from Eli Lilly and Company.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2024-11-01FDA Approved: SOLIQUA 100/33 — Supplemental Application (Sanofi-Aventis U.S. LLC)
FDA approved a supplemental application to authorize SOLIQUA 100/33, a fixed-ratio combination of insulin glargine and lixisenatide, for the…
-
FDA approval · 2024-11-01FDA Approved: XULTOPHY 100/3.6 — Supplemental Application (Novo Nordisk)
FDA approved a supplemental application for XULTOPHY 100/3.6 (insulin degludec and liraglutide) from Novo Nordisk, expanding the product's a…
-
CLINICAL_TRIALS trial_result · 2024-11-01Clinical Trial Update: A Remotely Delivered Episodic Future Thinking Intervention to Improve Management of Type 2 Diabetes [Phase 1, Phase 2]
The study reports the completion of a Phase 1/Phase 2 clinical trial evaluating a remotely delivered episodic future thinking intervention t…
-
CLINICAL_TRIALS research · 2024-11-01Clinical Trial Update: A Phase I Clinical Study to Evaluate the Effect of GZR18 Injection on the Pharmacokinetics of Oral Metformin Hydrochloride Tablets in Overweight/Obese Subjects [Phase 1]
This clinical trial update describes a Phase 1 study to evaluate the effect of GZR18 injection on the pharmacokinetics of oral metformin hyd…
-
CLINICAL_TRIALS trial_result · 2024-11-01Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of K-757 and K-833 in Overweight/Obese Patients With Type 2 Diabetes [Phase 1]
Phase 1 study assessing safety, tolerability, pharmacokinetics, and pharmacodynamics of K-757 and K-833 in overweight/obese patients with Ty…
-
CLINICAL_TRIALS trial_result · 2024-10-31Clinical Trial Update: A Study to Evaluate ASP8232 as Add-On Therapy to Angiotensin Converting Enzyme Inhibitor (ACEi) or Angiotensin Receptor Blocker (ARB) in Reducing Albuminuria in Patients With Type 2 Diabetes and Chronic Kidney Disease [Phase 2]
A Phase 2 study evaluating ASP8232 as add-on therapy to ACE inhibitors or ARBs to reduce albuminuria in patients with type 2 diabetes and ch…
-
CLINICAL_TRIALS trial_result · 2024-10-31Clinical Trial Update: Aerobic Plus Resistance Training and Insulin Sensitivity in African American Men [NA]
Completed clinical trial evaluating whether a combination of aerobic and resistance training improves insulin sensitivity in African America…
-
CLINICAL_TRIALS research · 2024-10-31Clinical Trial Update: Effect of SGLT2 Inhibitors on NAFLD in Type 2 Diabetic Patients with Diabetic Nephropathy
Clinical trial status update showing NOT_YET_RECRUITING for the study on SGLT2 inhibitors' effect on non-alcoholic fatty liver disease in pa…
-
CLINICAL_TRIALS trial_result · 2024-10-31Clinical Trial Update: Personalised Medicine in Pre-diabetes and Early Type 2 Diabetes [NA]
The document notes that a Garvan Institute-sponsored trial on personalized medicine for prediabetes and early type 2 diabetes has completed.
-
CLINICAL_TRIALS other · 2024-10-31Clinical Trial Update: A Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety of ASP8232 in Subjects With Renal Impairment and in Type 2 Diabetes Mellitus Subjects With Chronic Kidney Disease [Phase 1, Phase 2]
A completed Phase 1/2 trial evaluating the pharmacokinetics, pharmacodynamics, and safety of ASP8232 in subjects with chronic kidney disease…
-
CLINICAL_TRIALS trial_result · 2024-10-30Clinical Trial Update: iGlarLixi vs IDegAsp in Chinese Participants After OAD(s) [Phase 3]
A Phase 3 trial comparing iGlarLixi to IDegAsp in Chinese adults with Type 2 Diabetes Mellitus who are inadequately controlled on oral antid…
-
CLINICAL_TRIALS trial_result · 2024-10-30Clinical Trial Update: Impact of Integrated HIV/NCD Screening on HIV Testing Uptake and Engagement in HIV Care in Kisarawe, Tanzania [NA]
Completed clinical trial evaluating whether integrated HIV and non-communicable disease screening increases HIV testing uptake and engagemen…
-
CLINICAL_TRIALS research · 2024-10-29Clinical Trial Update: Dietary Fatty Acids As Complementary Therapy in Type 2 Diabetes Mellitus [Phase 1]
A Phase 1 clinical trial evaluating dietary fatty acids as a complementary therapy for Type 2 Diabetes Mellitus has completed. The study was…
-
CLINICAL_TRIALS research · 2024-10-28Clinical Trial Update: Strict Weight Management Based on GLP-1 RA for Ablation Outcomes in Overweight or Obese Patients with T2DM and AF [NA]
Clinical trial update on weight management using GLP-1 receptor agonists to influence ablation outcomes in overweight/obese patients with ty…
-
CLINICAL_TRIALS trial_result · 2024-10-28Clinical Trial Update: Effects of VLCKD in Metabolic Syndrome [NA]
A clinical trial is evaluating the effects of a very low calorie ketogenic diet (VLCKD) on metabolic syndrome and related conditions, includ…
-
CLINICAL_TRIALS trial_result · 2024-10-26Clinical Trial Update: the Effect of Fasted Versus Post-meal HIIT on Glycemic Control in Men With Type 2 Diabetes Mellitus [NA]
A completed clinical trial evaluating the effects of fasted versus post-meal high-intensity interval training on glycemic control in men wit…
-
CLINICAL_TRIALS research · 2024-10-26Clinical Trial Update: Butyrate-enriched Triglyceride and Diabetes Prevention [NA]
This clinical trial update describes a study evaluating a butyrate-enriched triglyceride for diabetes prevention. The study targets individu…
-
EMA approval · 2024-10-25EMA Authorised: Suliqua (insulin glargine;lixisenatide) — Sanofi Winthrop Industrie
The EMA authorised Suliqua, a fixed-dose combination of insulin glargine and lixisenatide, for the treatment of Type 2 diabetes mellitus; th…
-
CLINICAL_TRIALS trial_result · 2024-10-24Clinical Trial Update: Return of First-phase Insulin Secretion in Type 2 Diabetes is Associated With Depletion of Pancreas Lipid [NA]
A completed clinical trial update links the restoration of first-phase insulin secretion in Type 2 diabetes with depletion of pancreatic lip…
-
CLINICAL_TRIALS trial_result · 2024-10-24Clinical Trial Update: Study of Duodenal Mucosal RF Vapor Ablation in Subjects With Type-2 Diabetes Mellitus [NA]
Clinical trial evaluating duodenal mucosal RF vapor ablation as a treatment for Type 2 diabetes mellitus is currently recruiting.